STAAR Surgical Company (STAA) Financials

NASDAQ:STAA

Market Cap

2.00B

Total Revenue

284.39M

Gross Profit

223.38M

Operating Income

43.80M

Net Income

39.01M

Metric	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022
revenue	72,215,000	74,987,000	77,123,000	82,432,000	90,611,000	123,954,000	150,185,000	163,460,000	230,472,000	284,391,000
costOfRevenue	21,906,000	26,164,000	24,400,000	24,063,000	26,331,000	32,444,000	38,231,000	45,098,000	51,835,000	61,008,000
grossProfit	50,309,000	48,823,000	52,723,000	58,369,000	64,280,000	91,510,000	111,954,000	118,362,000	178,637,000	223,383,000
researchAndDevelopmentExpenses	6,708,000	12,363,000	14,761,000	20,294,000	19,116,000	22,028,000	25,298,000	31,918,000	33,862,000	35,983,000
sellingAndMarketingExpenses	23,888,000	25,879,000	23,695,000	28,478,000	28,130,000	38,600,000	45,491,000	45,764,000	67,294,000	88,856,000
generalAndAdministrativeExpenses	18,810,000	18,481,000	19,604,000	22,252,000	20,665,000	24,287,000	29,313,000	33,911,000	44,142,000	54,742,000
sellingGeneralAndAdministrativeExpenses	42,698,000	44,360,000	43,299,000	50,730,000	48,795,000	62,887,000	74,804,000	79,675,000	111,436,000	143,598,000
operatingExpenses	49,609,000	56,850,000	58,060,000	71,024,000	67,911,000	84,915,000	100,102,000	111,593,000	145,298,000	179,581,000
operatingIncome	700,000	-8,027,000	-5,337,000	-12,655,000	-3,631,000	6,595,000	11,852,000	6,769,000	33,339,000	43,802,000
totalOtherIncomeExpensesNet	525,000	-515,000	-190,000	323,000	1,447,000	-121,000	1,174,000	1,498,000	-2,035,000	2,000,000
ebitda	3,396,000	-5,135,000	-2,127,000	-9,290,000	-1,096,000	9,895,000	16,068,000	9,000,000	39,945,000	50,018,000
depreciationAndAmortization	2,151,000	2,460,000	2,401,000	2,892,000	3,354,000	2,464,000	4,216,000	2,231,000	6,606,000	6,216,000
interestIncome	59,000	51,000	50,000	3,000	--	--	--	238,000	--	--
interestExpense	170,000	154,000	128,000	115,000	-112,000	165,000	--	--	-38	2,448,000
incomeBeforeTax	1,114,000	-8,645,000	-5,605,000	-12,444,000	-2,296,000	6,639,000	13,026,000	8,267,000	31,304,000	45,802,000
incomeTaxExpense	716,000	-253,000	928,000	-315,000	-157,000	1,671,000	-1,022,000	2,354,000	6,803,000	6,797,000
netIncome	398,000	-8,392,000	-6,533,000	-12,129,000	-2,139,000	4,968,000	14,048,000	5,913,000	24,501,000	39,005,000
eps	0.01	-0.22	-0.17	-0.3	-0.052	0.12	0.32	0.13	0.52	0.81
epsdiluted	0.01	-0.22	-0.17	-0.3	-0.052	0.11	0.3	0.12	0.5	0.78
weightedAverageShsOut	36,706,000	38,091,000	39,260,000	40,329,000	41,004,000	42,587,000	44,493,000	45,605,000	47,210,000	47,987,000
weightedAverageShsOutDil	38,607,000	38,091,000	39,260,000	40,329,000	41,004,000	45,257,000	46,895,000	47,953,000	49,456,000	49,380,000
costAndExpenses	71,515,000	83,014,000	82,460,000	95,087,000	94,242,000	117,359,000	138,333,000	156,691,000	197,133,000	240,589,000
otherExpenses	486,000	381,000	759,000	470,000	628,000	715,000	703,000	396,000	967,000	1,259,000

Key Facts

Industry

Medical Instruments & Supplies

Sector

Healthcare

Headquarters

Lake Forest, CA, US

Website

staar.com

CEO

Mr. Thomas G. Frinzi

Employees

882

About the Company

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.